tiprankstipranks
Profound Medical (PROF)
NASDAQ:PROF
US Market
PROF
Profound Medical
RESEARCH TOOLSreports

Profound Medical (PROF) Financial Statements

80 Followers

Profound Medical Financial Overview

Profound Medical's market cap is currently $249.01M. The company's EPS TTM is $-1.24; its P/E ratio is -6.41; Profound Medical is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 16.38MC$ 10.68MC$ 7.20MC$ 6.68MC$ 6.87M
Gross ProfitC$ 11.59MC$ 7.04MC$ 4.38MC$ 3.02MC$ 2.95M
Operating IncomeC$ -41.98MC$ -33.06MC$ -28.62MC$ -29.60MC$ -30.29M
EBITDAC$ -41.41MC$ -32.13MC$ -27.00MC$ -26.60MC$ -28.65M
Net IncomeC$ -43.32MC$ -27.82MC$ -28.57MC$ -28.67MC$ -30.70M
Balance Sheet
Cash & Short-Term InvestmentsC$ 59.61MC$ 54.91MC$ 26.21MC$ 46.94MC$ 66.59M
Total AssetsC$ 140.62MC$ 70.23MC$ 43.91MC$ 64.42MC$ 86.78M
Total DebtC$ 4.70MC$ 5.12MC$ 7.87MC$ 8.30MC$ 1.38M
Net DebtC$ -54.91MC$ -49.79MC$ -18.35MC$ -38.29MC$ -65.78M
Total LiabilitiesC$ 74.30MC$ 9.81MC$ 12.73MC$ 12.42MC$ 6.16M
Stockholders' EquityC$ 66.31MC$ 60.42MC$ 31.18MC$ 52.48MC$ 79.95M
Cash Flow
Free Cash FlowC$ -39.05MC$ -23.45MC$ -22.30MC$ -25.80MC$ -22.95M
Operating Cash FlowC$ -38.88MC$ -23.45MC$ -22.61MC$ -25.80MC$ -22.36M
Investing Cash FlowC$ -246.24KC$ 0.00C$ 0.00C$ 0.00C$ -583.04K
Financing Cash FlowC$ 41.86MC$ 54.70MC$ 1.76MC$ 7.03MC$ 5.95M
Currency in CAD

Profound Medical Earnings and Revenue History

Income Statement >

Profound Medical Debt to Assets

Balance Sheet >

Profound Medical Cash Flow

Cash Flow >

Profound Medical Forecast EPS vs Actual EPS

Earnings >